MARKET

RVPH

RVPH

Reviva Pharmaceutcls Hldgs Inc
NASDAQ
1.110
+0.070
+6.73%
After Hours: 1.100 -0.01 -0.90% 18:57 03/14 EDT
OPEN
1.050
PREV CLOSE
1.040
HIGH
1.130
LOW
1.050
VOLUME
770.96K
TURNOVER
--
52 WEEK HIGH
4.280
52 WEEK LOW
0.6000
MARKET CAP
51.70M
P/E (TTM)
-0.9952
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RVPH last week (0303-0307)?
Weekly Report · 5d ago
Weekly Report: what happened at RVPH last week (0224-0228)?
Weekly Report · 03/03 11:59
Weekly Report: what happened at RVPH last week (0217-0221)?
Weekly Report · 02/24 11:59
Reviva Pharmaceuticals Approves Executive Compensation Changes
TipRanks · 02/18 22:17
Weekly Report: what happened at RVPH last week (0210-0214)?
Weekly Report · 02/17 11:55
Unusually active option classes on open February 12th
TipRanks · 02/12 14:40
Weekly Report: what happened at RVPH last week (0203-0207)?
Weekly Report · 02/10 11:48
Weekly Report: what happened at RVPH last week (0127-0131)?
Weekly Report · 02/03 11:54
More
About RVPH
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops, and seeks to commercialize therapeutics for diseases representing unmet medical needs. The Company’s pipeline focuses on the central nervous system and respiratory and metabolic diseases. Its pipeline includes two drug candidates, RP5063 (brilaroxazine) and RP1208. Its lead drug candidate, brilaroxazine, is in clinical development and is to treat multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), behavioral and psychotic symptoms of dementia or Alzheimer’s disease (BPSD), and Parkinson’s disease psychosis. Brilaroxazine is also ready for clinical development for two respiratory indications, including pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF). Its RP1208 drug candidate is a triple reuptake inhibitor (TRI).

Webull offers Reviva Pharmaceuticals Holdings Inc stock information, including NASDAQ: RVPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVPH stock methods without spending real money on the virtual paper trading platform.